Efficacy and safety of linezolid in the treatment of gram-positive coccus in-fection in the elderly
10.3969/j.issn.1671-9638.2016.08.015
- VernacularTitle:利奈唑胺治疗老年患者革兰阳性球菌感染的疗效及安全性
- Author:
Ming HONG
;
Kuanpeng GUO
;
Lin ZHANG
- Publication Type:Journal Article
- Keywords:
linezolid;
gram-positive coccus;
the elderly;
drug therapy;
adverse effect
- From:
Chinese Journal of Infection Control
2016;15(8):599-602
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of linezolid in the treatment of gram-positive coccus in-fection in the elderly.Methods Clinical data of patients (>60 years old)infected with gram-positive coccus and treated with linezolid for 10 days between January 2013 and December 2014 were collected,the therapeutic efficacy of linezolid were analyzed,laboratory indexes before and 14 days after linezolid treatment were compared,possible adverse effects were analyzed.Results A total of 70 old patients were enrolled,the majority of patients were infec-ted in lower respiratory tract (62.86%)and were infected with Staphylococcus aureus (42.86%,of which 19 were MRSA),more than 80% of the patients were >70 years old,had length of stay > 30 days,and admitted in ICU, more than 70% of the patients were with deep venous catheterization and indwelling urinary catheterization.Platelet count (PLT)after 14 days of linezolid treatment was significantly lower than before treatment([132.00±45.00]× 109/L vs [156.00±78.00]×109/L,P =0.009);the total therapeutic efficacy of linezolid was 81 .43%(57/70), while the rate of adverse effects was 17.14% (12/70).Conclusion Linezolid is effective for treatment of gram-posi-tive coccus infection in the elderly,and may be a good choice of empirical treatment.PLT should be intensively mo-nitored during the process of linezolid therapy.
